Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-053766

Chief Scientific Officer sold 11,685 shares at an average $34.25 ($400,231)

  • Chief Scientific Officer acquired 11,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-25 Exercise or conversion : show line 1 in the form +3,895 $6.32 $24,616 73,255 D
2021-08-25 Sale : show line 2 in the form −3,895 $34.09 $132,781 69,360 D
2021-08-26 Exercise or conversion : show line 3 in the form +3,895 $6.32 $24,616 73,255 D
2021-08-26 Sale : show line 4 in the form −3,895 $33.89 $132,002 69,360 D
2021-08-27 Exercise or conversion : show line 5 in the form +3,895 $6.32 $24,616 73,255 D
2021-08-27 Sale : show line 6 in the form −961 $34.18 $32,847 72,294 D
2021-08-27 Sale : show line 7 in the form −2,934 $34.97 $102,602 69,360 D
Open-market sales · 11,685 sh · avg $34.25 · $400,231

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-08-25 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,895 101,270 D
2021-08-26 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −3,895 97,375 D
2021-08-27 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −3,895 93,480 D
Loading xslF345X03/doc4.xml…